MEDIWOUND LTD (MDWD) — insider trading
Health Care · NASDAQ
MEDIWOUND LTD (MDWD) has 6 reported SEC Form 4 insider transactions in our data, including 6 open-market purchases among the most recent 6 (latest 2026-06-03).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | SHAMIR NACHUM | Director | Open-market purchase | 5,825 | $14.00 | $81.5K | Form 4 |
| 2026-06-03 | SHAMIR NACHUM | Director | Open-market purchase | 175 | $13.98 | $2.4K | Form 4 |
| 2026-06-01 | Fox David Morton | Director | Open-market purchase | 1,797 | $14.00 | $25.1K | Form 4 |
| 2026-06-01 | Fox David Morton | Director | Open-market purchase | 10 | $14.23 | $142 | Form 4 |
| 2026-06-01 | Fox David Morton | Director | Open-market purchase | 1,730 | $14.23 | $24.6K | Form 4 |
| 2026-05-29 | Rubinstein Samuel | Director | Open-market purchase | 150 | $14.33 | $2.1K | Form 4 |
Ask the chat about MDWD's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: MEDIWOUND LTD (MDWD).
Last updated 2026-06-03 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.